spacerspacerspacer
spacerspacerspacerspacerspacerspacerspacerspacerspacer

Hyperkalemia : current and classic

1. Ahee P, Crowe AV. The management of hyperkalemia in the emergency department. J Accid Emerg Med. 2000 May;17(3):188-91.

2. Alappan R, et al. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Int Med 1996; 124; 316-2

3. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kid Int 1990; 38:869-72.

4. Androgue HJ, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Med (Baltimore) 1986; 65(3): 163-72.

5. Androgue HJ, Madias NE. Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med 1981; 71:456-67.

6. Don BR, et al. Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med 1990; 88:1290-2.

7.Gamba G. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. Am J Physiol Renal Physiol. 2005 Feb;288(2):F245-52.

8. Gennari FJ. Disorders of potassium homeostasis. Hypokalemia and hyperkalemia. Crit Care Clin 2002;18:273-88.

11. Giebisch GH. A trail of research on potassium. Kidney Int. 2002 Nov;62(5):1498-512.

9. Greenberg S et al. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Int Med 1993; 119:291-5.

10. Kleyman TR,et al. A mechanism for pentamidine-induced Hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med 1995; 122:103-6.

11. Mount DB et al. Disorders of potassium balance. Ch 21 in : The Kidney, 7th Ed. Editor Brenner BM, Saunders, 2004.

12. Oster JR, et al. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med 1995; 98(6):575-86.

13. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 2002;347:1256-61.

14. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004;351:585-92.

15. Pitt B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.

16. Rimmer JM, Horn JF, Gennari FJ. Hyperkalemia as a complication of drug therapy. Arch Intern Med 1987; 147(5):867-9.

17. Torpy DJ et al. Hyper- and hypoaldosteronism. Vitam Horm. 1999;57:177-216.

18. Velaquez A et al. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Int Med 1993; 119:296-301.

End of Page

Guide to Optimum Use | Copyright | Editorial Board | Disclaimer | ©'08 Emedicine.ie